Physician

Moshe Chaim Chasky, M.D.

According to 2025 Medicare claims, Moshe Chasky, M.D. (NPI: 1508042581) practices hematology/oncology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is ALLIANCE CANCER SPECIALISTS P.C. (NPI: 1487923686; TIN: 452552343) and primary practice location at 19020-6415.

Chasky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 524 traditional Medicare patients, billed 249,812 HCPCS/CPT codes, and received $5,163,738 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,755 prescription claims across 256 beneficiaries totaling $3,791,924 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 58 claims. Open Payments data shows 175 records totaling $8,919. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,323,174 to $5,163,738. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,003,747 to $3,791,924. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,448 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	337	133,237	$2,323,174
2016	330	174,166	$2,392,542
2017	392	125,038	$1,990,162
2018	373	174,926	$2,525,559
2019	379	166,507	$1,801,260
2020	409	142,681	$2,167,741
2021	467	208,263	$3,189,635
2022	358	215,341	$3,801,927
2023	369	167,200	$3,732,961
2024	524	249,812	$5,163,738

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	164	1,145	$1,003,747
2016	171	1,187	$1,644,290
2017	152	1,170	$1,832,663
2018	196	1,298	$2,526,234
2019	182	1,450	$2,418,563
2020	189	1,586	$3,134,671
2021	221	1,698	$3,576,336
2022	201	1,557	$2,967,993
2023	189	1,322	$2,588,655
2024	256	1,755	$3,791,924

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	93	$6,895
2016	N/R	110	$6,608
2017	N/R	15	$4,527
2018	N/R	19	$3,970
2019	N/R	14	$1,802
2020	N/R	24	$1,877
2021	N/R	21	$1,291
2022	N/R	14	$494
2023	N/R	N/R	N/R
2024	N/R	58	$9,777

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	257	888	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	202	245	$65
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	81	178	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	296	559	$13
96372	Injection of drug or substance under skin or into muscle	94	671	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	36	1,008	$823,211
Lenalidomide	Lenalidomide	37	1,015	$543,348
Revlimid	Lenalidomide	15	413	$284,242
Xtandi	Enzalutamide	20	600	$269,407
Calquence	Acalabrutinib Maleate	17	510	$256,915

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	20	$4,989
B4224	Parenteral nutrition administration kit, per day	N	N/R	20	$3,721
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	18	$1,067

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	175	$8,919	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Moshe Chaim Chasky, M.D.?

Tedicare shows public-source Medicare data for Moshe Chaim Chasky, M.D. (NPI 1508042581), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Moshe Chaim Chasky, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Moshe Chaim Chasky, M.D.?

Moshe Chaim Chasky, M.D. is linked to ALLIANCE CANCER SPECIALISTS P.C. (billing NPI 1487923686) in the available physician profile data.

Does Moshe Chaim Chasky, M.D. have Open Payments data?

Moshe Chaim Chasky, M.D. has 175 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.